Publication Name	World Journal of Clinical Cases
Manuscript ID	86584
Country	China

Received	2023-06-28 13:56
Peer-Review Started	2023-06-26 09:49
To Make the First Decision
Return for Revision	2023-08-16 05:33
Revised	2023-08-25 13:45
Second Decision	2023-09-21 02:52
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2023-09-22 07:54
Articles in Press	2023-09-22 07:54
Publication Fee Transferred
Edit the Manuscript by Language Editor	2023-09-18 03:08
Typeset the Manuscript	2023-09-27 06:48
Publish the Manuscript Online	2023-10-13 14:28

ISSN	2307-8960 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Hematology
Manuscript Type	Case Report
Article Title	Rituximab combined with Bruton tyrosine kinase inhibitor to treat elderly diffuse large B-cell lymphoma patients: Two case reports
Manuscript Source	Unsolicited Manuscript
All Author List	Cang-Jian Zhang and Min-Lei Zhao
ORCID	Author(s) ORCID Number Cang-Jian Zhang http://orcid.org/0000-0001-8966-3545 Min-Lei Zhao http://orcid.org/0009-0004-3764-2514
Funding Agency and Grant Number
Corresponding Author	Min-Lei Zhao, Doctor, N/A, Department of Hematology, Lishui Municipal Central Hospital, No. 289 Kuocang Road, Lishui 323000, Zhejiang Province, China. minleizhao@163.com
Key Words	Diffuse large B-cell lymphoma; Rituximab; Bruton tyrosine kinase inhibitors; Elderly patients; Case report
Core Tip	The clinical data of two elderly patients with diffuse large B-cell lymphoma (DLBCL) who received rituximab combined with Bruton tyrosine kinase (BTK) inhibitor (BTKi) in our hospital were retrospectively analyzed, and the literature was reviewed. The patients were treated with chemotherapy using the R-miniCHOP regimen for 2 courses. Then, they received rituximab in combination with BTKi. The treatment experience in these patients demonstrates the potential efficacy of rituximab combined with BTKi to treat elderly DLBCL patients, thus providing a new treatment strategy.
Publish Date	2023-10-13 14:28
Citation	Zhang CJ, Zhao ML. Rituximab combined with Bruton tyrosine kinase inhibitor to treat elderly diffuse large B-cell lymphoma patients: Two case reports. World J Clin Cases 2023; 11(29): 7170-7178
URL	https://www.wjgnet.com/2307-8960/full/v11/i29/7170.htm
DOI	https://dx.doi.org/10.12998/wjcc.v11.i29.7170

Full Article (PDF)	WJCC-11-7170-with-cover.pdf
Full Article (Word)	WJCC-11-7170.docx
CARE Checklist–2016	86584-CARE Checklist (2016).pdf
Manuscript File	86584_Auto_Edited-CL-Ma JY-JLW.docx
Answering Reviewers	86584-Answering reviewers.pdf
Audio Core Tip	86584-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	86584-Conflict-of-interest statement.pdf
Copyright License Agreement	86584-Copyright license agreement.pdf
Signed Consent for Treatment Form(s) or Document(s)	86584-Informed consent statement.pdf
Non-Native Speakers of English Editing Certificate	86584-Language certificate.pdf
Peer-review Report	86584-Peer-review(s).pdf
Scientific Misconduct Check	86584-Bing-Lin C-2.png
Scientific Editor Work List	86584-Scientific editor work list.pdf